TipRanks
Go Ultimate55% OFF

CASI Pharmaceuticals (CASIF) Ownership - Who Owns CASI Pharmaceuticals?

CASI Pharmaceuticals (CASIF) Ownership Overview

  • <0.01% Other Institutional Investors
  • 100.00% Public Companies and Individual Investors

The ownership structure of CASI Pharmaceuticals (CASIF) stock is a mix of institutional, retail, and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, and 100.00% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

CASIF top shareholders
Holder# of SharesType% HoldingValue
Michael Rockefeller133,406Institution0.65%17,343

FAQ

What percentage of CASI Pharmaceuticals (CASIF) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of CASI Pharmaceuticals (CASIF) stock is held by institutional investors.
What percentage of CASI Pharmaceuticals (CASIF) stock is held by retail investors?
According to the latest TipRanks data, approximately 100.00% of CASI Pharmaceuticals (CASIF) stock is held by retail investors.
Who owns the most shares of CASI Pharmaceuticals (CASIF)?
Michael Rockefeller owns the most shares of CASI Pharmaceuticals (CASIF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.